Home › Calculator › ELTP Dividend Calculator 2026
ELTP Dividend DRIP Calculator 2026
769.23% YieldHealthcareElite Pharmaceuticals, Inc. · OTC
Price: $0.26 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ELTP pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ELTP snowball 📈
$10,000 in ELTP → $653.73M in 10 years · $406,186.13/month
About Elite Pharmaceuticals, Inc. (ELTP) — Dividend Analysis 2026
Elite Pharmaceuticals, Inc. (ELTP) is a specialized pharmaceutical company focused on the creation and manufacturing of generic medications, as well as oral, controlled-release drug formulations. Its business activities are primarily divided into two segments: Abbreviated New Drug Applications (ANDAs) for generic products and New Drug Applications (NDAs) for branded pharmaceuticals. The company's extensive product line includes drugs that it either owns, licenses, or produces through contract manufacturing. This portfolio features a variety of generic and oral-dose pharmaceutical products designed to address diverse medical needs. For instance, it offers Phentermine HCl 37.5mg tablets, marketed under the Adipex-P brand, and Phendimetrazine Tartrate 35mg tablets, known as Bontril, both utilized in bariatric medicine. Its offerings also extend to Naltrexone HCl 50mg tablets (Revia brand) for pain management, and Isradipine 2.5mg and 5mg capsules for cardiovascular conditions. Elite Pharmaceuticals further supplies various strengths of Oxycodone HCl immediate release tablets (5mg, 10mg, 15mg, 20mg, and 30mg) under the Roxycodone brand for pain relief, as well as Trimipramine Maleate Immediate Release antidepressant capsules (Surmontil brand). For central nervous system disorders, the company provides Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets, commonly associated with the Adderall brand. Additionally, its products include Dantrolene Sodium capsules (Dantrium brand) for muscle relaxation, SequestOX (an immediate-release Oxycodone formulation combined with Naltrexone), Loxapine Succinate capsules (Loxapine brand) for antipsychotic treatment, and a combination of Acetaminophen and Codeine Phosphate for managing mild to moderate pain, alongside various antibiotic products. Beyond its own product portfolio, Elite Pharmaceuticals also undertakes contract manufacturing of controlled-release products for external parties, covering therapeutic areas such as pain, allergies, bariatrics, and infections. The company is actively engaged in developing a new generation of opioid products specifically engineered to deter abuse. Established in 1997, Elite Pharmaceuticals, Inc. maintains its corporate headquarters in Northvale, New Jersey.
Compare ELTP with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ELTP DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ELTP position with:
🌍 ELTP Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ELTP.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 769.23% | 766.43% | $76,923 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 653.85% | 651.05% | $65,385 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 615.38% | 612.58% | $61,538 / yr |
| 🇬🇧 UK ISA | 0% | 769.23% | 766.43% | $76,923 / yr |
| 🇬🇧 UK Taxable | 8.75% | 701.92% | 699.12% | $70,192 / yr |
| 🇨🇦 TFSA | 0% | 769.23% | 766.43% | $76,923 / yr |
| 🇨🇦 CA Taxable | 25% | 576.92% | 574.12% | $57,692 / yr |
| 🇦🇺 Super (pension) | 15% | 653.85% | 651.05% | $65,385 / yr |
| 🇦🇺 AU Taxable | 30% | 538.46% | 535.66% | $53,846 / yr |
| 🇩🇪 DE Taxable | 26.375% | 566.35% | 563.55% | $56,635 / yr |
| 🇫🇷 FR Taxable | 30% | 538.46% | 535.66% | $53,846 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ELTP Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ELTP Dividend Payment Schedule
ELTP pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ELTP vs Healthcare Benchmarks
How ELTP compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ELTP sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ELTP Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-01-09 | 2,500,000 | $0.03 | $75.0K | ||
| M-Exempt | 2026-01-09 | 2,500,000 | $0.03 | $75.0K | ||
| Sale | 2025-10-02 | 800,000 | $0.62 | $499.2K | ||
| M-Exempt | 2025-08-25 | 2,500,000 | $0.03 | $75.0K | ||
| M-Exempt | 2025-08-25 | 2,500,000 | $0.03 | $75.0K | ||
| Sale | 2025-08-22 | 500,000 | $0.52 | $262.1K | ||
| Buy | 2025-07-10 | 16,366 | $0.59 | $9.6K | ||
| Sale | 2025-07-08 | 200,000 | $0.58 | $115.8K | ||
| M-Exempt | 2025-07-03 | 2,500,000 | $0.03 | $75.0K | ||
| M-Exempt | 2025-07-03 | 2,500,000 | $0.03 | $75.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ELTP dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Elite Pharmaceuticals, Inc. (ELTP) is currently trading at $0.26, 63% below its 52-week high. The current dividend yield is 769.23% based on an annual payout of $2.00 per share.
ELTP (Elite Pharmaceuticals, Inc.) — 769.23% Dividend Yield Analysis
Elite Pharmaceuticals, Inc. (ELTP) is a healthcare stock currently trading at $0.26 with a dividend yield of 769.23%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (769.23%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.